Hematopoietic Stem Cell TransplantationTransplantation, AutologousStem Cell TransplantationTransplantation, HomologousTransplantation ConditioningPeripheral Blood Stem Cell TransplantationHematopoietic Stem CellsStem CellsMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsMelphalanGraft vs Host DiseaseTreatment OutcomeCombined Modality TherapyHematologic NeoplasmsBone Marrow TransplantationRemission InductionSalvage TherapyDisease-Free SurvivalRecurrenceHodgkin DiseaseCyclophosphamideEtoposideHematopoietic Stem Cell MobilizationMyeloablative AgonistsLymphoma, Non-HodgkinTransplantationSurvival RateRetrospective StudiesAntigens, CD34CytarabineTissue DonorsHistocompatibility TestingCarmustineStem Cell NicheSurvival AnalysisBone Marrow PurgingWhole-Body IrradiationGraft SurvivalThiotepaTransplantation ChimeraVincristineFollow-Up StudiesBusulfanCell DifferentiationAdult Stem CellsHematopoiesisAmyloidosisImmunocompromised HostHepatic Veno-Occlusive DiseaseImmunosuppressive AgentsLymphoma, Mantle-CellEmbryonic Stem CellsPrognosisMesenchymal Stem Cell TransplantationBoronic AcidsPyrazinesDexamethasoneDoxorubicinTime FactorsLeukemiaAntibodies, Monoclonal, Murine-DerivedLymphoma, FollicularThalidomideAntineoplastic AgentsKidney TransplantationAntineoplastic Agents, AlkylatingLymphoma, T-Cell, PeripheralGranulocyte Colony-Stimulating FactorAutograftsBone MarrowCell LineageBone Marrow CellsLiver TransplantationCord Blood Stem Cell TransplantationIfosfamideLymphomaLeukapheresisPluripotent Stem CellsInduction ChemotherapyFlow CytometryLeukemia, Myeloid, AcuteMice, Inbred C57BLPrednisoneHLA AntigensPancytopeniaCell TransplantationAnemia, AplasticPodophyllotoxinCells, CulturedNeoplasm, ResidualHistocompatibilityLymphoma, Large B-Cell, DiffuseCytomegalovirus InfectionsMaintenance ChemotherapyNeural Stem CellsMyelodysplastic SyndromesMesenchymal Stromal CellsProspective StudiesFetal Blood